Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-11 @ 4:13 AM
Study NCT ID:
NCT04091451
Status:
COMPLETED
Last Update Posted:
2025-12-04
First Post:
2019-09-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster
Sponsor:
GlaxoSmithKline
Organization: